Braegelmann, Christine <br/><br/>
Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients.  [electronic resource] 

 -  Experimental dermatology  05 2016 
 - 375-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0625 
<br/><br/><label>Standard No.: </label>10.1111/exd.12986  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Case-Control Studies<br/>Cells, Cultured<br/>Cytokines--metabolism<br/>Humans<br/>Lupus Erythematosus, Cutaneous--enzymology<br/>Phosphorylation<br/>Syk Kinase--metabolism